Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Bevacizumab With Nab-paclitaxel and Tegafur Gimeracil Oteracil Potassium Capsule (S-1) in Advanced Biliary Tract Adenocarcinoma

NCT07719738 is registered in ClinicalTrials.gov with Cancer Institute and Hospital, Chinese Academy of Medical Sciences as lead sponsor.

NCT NCT07719738
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07719738 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Bevacizumab With Nab-paclitaxel and Tegafur Gimeracil Oteracil Potassium Capsule (S-1) in Advanced Biliary Tract Adenocarcinoma
Lead sponsor
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase
Phase 2
Overall status
Completed
Start date
February 23, 2026
Completion date
February 23, 2026
Enrollment
32 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

biliary cancer metastatic